ArticleNature communications2025

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle.

Vishnu Kumarasamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.